Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch

BACKGROUND: Rotigotine is a unique dopamine agonist with activity across D1 through D5 receptors as well as select adrenergic and serotonergic sites. This study reports the 2-year follow-up safety and efficacy data of an ongoing open-label multicenter extension study (NCT00498186) of transdermal rot...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Högl, Birgit, Oertel, Wolfgang H, Stiasny-Kolster, Karin, Geisler, Peter, Beneš, Heike, García-Borreguero, Diego, Trenkwalder, Claudia, Poewe, Werner, Schollmayer, Erwin, Kohnen, Ralf
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2010
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2958158/
https://ncbi.nlm.nih.gov/pubmed/20920156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-10-86
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi